$ORGO
Organogenesis Holdings Inc.

2024 Q3 Form 10-Q Financial Statement

#000095017024094009 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $115.2M $130.2M
YoY Change 6.12% 11.01%
Cost Of Revenue $26.80M $29.20M
YoY Change 3.9% 10.95%
Gross Profit $88.38M $101.0M
YoY Change 6.82% 11.03%
Gross Profit Margin 76.73% 77.58%
Selling, General & Admin $71.80M $76.54M
YoY Change 11.79% 8.85%
% of Gross Profit 81.23% 75.76%
Research & Development $10.34M $15.59M
YoY Change -1.2% 42.5%
% of Gross Profit 11.7% 15.43%
Depreciation & Amortization $3.570M $3.366M
YoY Change 40.33% 51.08%
% of Gross Profit 4.04% 3.33%
Operating Expenses $82.14M $114.9M
YoY Change 9.97% 41.44%
Operating Profit $6.242M -$13.89M
YoY Change -22.46% -242.56%
Interest Expense -$471.0K $620.0K
YoY Change -206.08% 4.38%
% of Operating Profit -7.55%
Other Income/Expense, Net -$419.0K -$648.0K
YoY Change 1.45% 14.49%
Pretax Income $5.823M -$14.54M
YoY Change -23.75% -258.41%
Income Tax -$6.508M $2.503M
% Of Pretax Income -111.76%
Net Earnings $12.33M -$17.04M
YoY Change 289.36% -420.6%
Net Earnings / Revenue 10.71% -13.09%
Basic Earnings Per Share $0.09 -$0.13
Diluted Earnings Per Share $0.09 -$0.13
COMMON SHARES
Basic Shares Outstanding 132.6M 132.6M
Diluted Shares Outstanding 133.9M 132.6M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $94.34M $89.90M
YoY Change -3.93% 1.11%
Cash & Equivalents $94.34M $89.90M
Short-Term Investments
Other Short-Term Assets $15.86M $11.46M
YoY Change 55.5% 34.25%
Inventory $27.04M $26.88M
Prepaid Expenses
Receivables $101.3M $105.9M
Other Receivables $0.00 $0.00
Total Short-Term Assets $238.5M $234.2M
YoY Change 5.73% 8.21%
LONG-TERM ASSETS
Property, Plant & Equipment $89.87M $89.95M
YoY Change -23.52% -19.56%
Goodwill $28.77M $28.77M
YoY Change 0.0% 0.0%
Intangibles $13.30M $14.14M
YoY Change -22.22% -22.88%
Long-Term Investments
YoY Change
Other Assets $5.013M $5.851M
YoY Change 279.49% 320.03%
Total Long-Term Assets $207.8M $209.0M
YoY Change -12.35% -10.65%
TOTAL ASSETS
Total Short-Term Assets $238.5M $234.2M
Total Long-Term Assets $207.8M $209.0M
Total Assets $446.3M $443.2M
YoY Change -3.53% -1.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.97M $29.39M
YoY Change -10.5% 7.3%
Accrued Expenses $36.10M $38.02M
YoY Change 3.17% 36.83%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $7.111M $6.883M
YoY Change 6.13% 20.99%
Total Short-Term Liabilities $77.28M $85.73M
YoY Change -5.16% 16.71%
LONG-TERM LIABILITIES
Long-Term Debt $57.17M $59.05M
YoY Change -11.09% -7.58%
Other Long-Term Liabilities $1.294M $1.268M
YoY Change 8.65% 6.55%
Total Long-Term Liabilities $1.294M $1.268M
YoY Change 8.65% 6.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $77.28M $85.73M
Total Long-Term Liabilities $1.294M $1.268M
Total Liabilities $167.7M $179.7M
YoY Change -9.71% 0.35%
SHAREHOLDERS EQUITY
Retained Earnings -$47.78M -$60.11M
YoY Change 18.27% 37.97%
Common Stock $326.3M $323.6M
YoY Change 2.86% 2.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $278.5M $263.5M
YoY Change
Total Liabilities & Shareholders Equity $446.3M $443.2M
YoY Change -3.53% -1.59%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $12.33M -$17.04M
YoY Change 289.36% -420.6%
Depreciation, Depletion And Amortization $3.570M $3.366M
YoY Change 40.33% 51.08%
Cash From Operating Activities $8.695M $4.738M
YoY Change -48.03% -45.2%
INVESTING ACTIVITIES
Capital Expenditures $2.569M $1.880M
YoY Change -57.04% -74.93%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.569M -$1.880M
YoY Change -57.04% -74.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.677M -1.727M
YoY Change 16.46% 63.85%
NET CHANGE
Cash From Operating Activities 8.695M 4.738M
Cash From Investing Activities -2.569M -1.880M
Cash From Financing Activities -1.677M -1.727M
Net Change In Cash 4.449M 1.131M
YoY Change -52.21% 1116.13%
FREE CASH FLOW
Cash From Operating Activities $8.695M $4.738M
Capital Expenditures $2.569M $1.880M
Free Cash Flow $6.126M $2.858M
YoY Change -43.01% 149.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001661181
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2024#AccountingStandardsUpdate201613Member
CY2024Q2 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet
CY2023Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37906
dei Entity Registrant Name
EntityRegistrantName
ORGANOGENESIS HOLDINGS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1329150
dei Entity Address Address Line1
EntityAddressAddressLine1
85 Dan Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Canton
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02021
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
575-0775
dei Security12b Title
Security12bTitle
Class A Common Stock, $0.0001 par value
dei Trading Symbol
TradingSymbol
ORGO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
132575002
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
89902000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103840000
CY2024Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
575000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
498000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
105945000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
81999000
CY2024Q2 us-gaap Inventory Net
InventoryNet
26883000
CY2023Q4 us-gaap Inventory Net
InventoryNet
28253000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10889000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10454000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
234194000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
225044000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
89947000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
116228000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14136000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15871000
CY2024Q2 us-gaap Goodwill
Goodwill
28772000
CY2023Q4 us-gaap Goodwill
Goodwill
28772000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
36572000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
40118000
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
33691000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
28002000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5851000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5990000
CY2024Q2 us-gaap Assets
Assets
443163000
CY2023Q4 us-gaap Assets
Assets
460025000
CY2024Q2 us-gaap Secured Debt Current
SecuredDebtCurrent
5758000
CY2023Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
5486000
CY2024Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1125000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1081000
CY2024Q2 orgo Current Portion Of Operating Lease Obligations Related Party
CurrentPortionOfOperatingLeaseObligationsRelatedParty
7357000
CY2023Q4 orgo Current Portion Of Operating Lease Obligations Related Party
CurrentPortionOfOperatingLeaseObligationsRelatedParty
8413000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4081000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4731000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
29390000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
30724000
CY2024Q2 orgo Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
38016000
CY2023Q4 orgo Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
30074000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
85727000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
80509000
CY2024Q2 us-gaap Secured Long Term Debt
SecuredLongTermDebt
57731000
CY2023Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
60745000
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1314000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1888000
CY2024Q2 orgo Operating Lease Liability Noncurrent Related Party
OperatingLeaseLiabilityNoncurrentRelatedParty
10139000
CY2023Q4 orgo Operating Lease Liability Noncurrent Related Party
OperatingLeaseLiabilityNoncurrentRelatedParty
11954000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23483000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
25053000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1268000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1213000
CY2024Q2 us-gaap Liabilities
Liabilities
179662000
CY2023Q4 us-gaap Liabilities
Liabilities
181362000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
133302786
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132044944
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132574238
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131316396
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
13000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
13000
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
323602000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
319621000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-60114000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40971000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
263501000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
278663000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
443163000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
460025000
CY2024Q2 us-gaap Revenues
Revenues
130234000
CY2023Q2 us-gaap Revenues
Revenues
117316000
us-gaap Revenues
Revenues
240210000
us-gaap Revenues
Revenues
224958000
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
29198000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
26316000
us-gaap Cost Of Revenue
CostOfRevenue
57894000
us-gaap Cost Of Revenue
CostOfRevenue
52923000
CY2024Q2 us-gaap Gross Profit
GrossProfit
101036000
CY2023Q2 us-gaap Gross Profit
GrossProfit
91000000
us-gaap Gross Profit
GrossProfit
182316000
us-gaap Gross Profit
GrossProfit
172035000
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
76540000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
70317000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
148862000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
144151000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15587000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10938000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28397000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22140000
CY2024Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
18842000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
18842000
CY2024Q2 orgo Write Down Of Capitalized Internal Use Software Costs
WriteDownOfCapitalizedInternalUseSoftwareCosts
3959000
orgo Write Down Of Capitalized Internal Use Software Costs
WriteDownOfCapitalizedInternalUseSoftwareCosts
3959000
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
114928000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
81255000
us-gaap Operating Expenses
OperatingExpenses
200060000
us-gaap Operating Expenses
OperatingExpenses
166291000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-13892000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
9745000
us-gaap Operating Income Loss
OperatingIncomeLoss
-17744000
us-gaap Operating Income Loss
OperatingIncomeLoss
5744000
CY2024Q2 us-gaap Interest Expense
InterestExpense
620000
CY2023Q2 us-gaap Interest Expense
InterestExpense
594000
us-gaap Interest Expense
InterestExpense
1134000
us-gaap Interest Expense
InterestExpense
1243000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-28000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
28000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
51000
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-648000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-566000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1139000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1192000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14540000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9179000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18883000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4552000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2503000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3863000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
260000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2205000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-17043000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
5316000
us-gaap Net Income Loss
NetIncomeLoss
-19143000
us-gaap Net Income Loss
NetIncomeLoss
2347000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132573153
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131293398
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132217463
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131189405
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132573153
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133066010
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132217463
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132475908
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
278663000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
180000
CY2024Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-1120000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2407000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-2100000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
278030000
CY2024Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-54000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2568000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-17043000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
263501000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
265669000
CY2023Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-298000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1914000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-2969000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
263701000
CY2023Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-34000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2299000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
5316000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
271282000
us-gaap Profit Loss
ProfitLoss
-19143000
us-gaap Profit Loss
ProfitLoss
2347000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6438000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4922000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1735000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2459000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
4364000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3893000
orgo Non Cash Interest Expense
NonCashInterestExpense
209000
orgo Non Cash Interest Expense
NonCashInterestExpense
215000
orgo Deferred Interest Expense
DeferredInterestExpense
213000
orgo Deferred Interest Expense
DeferredInterestExpense
245000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
2032000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
190000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5689000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-434000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-65000
orgo Adjustment For Excess And Obsolete Inventories
AdjustmentForExcessAndObsoleteInventories
-4469000
orgo Adjustment For Excess And Obsolete Inventories
AdjustmentForExcessAndObsoleteInventories
-3464000
us-gaap Share Based Compensation
ShareBasedCompensation
4975000
us-gaap Share Based Compensation
ShareBasedCompensation
4213000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
18842000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
orgo Write Down Of Capitalized Internal Use Software Costs
WriteDownOfCapitalizedInternalUseSoftwareCosts
3959000
orgo Write Down Of Capitalized Internal Use Software Costs
WriteDownOfCapitalizedInternalUseSoftwareCosts
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
25978000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4970000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2009000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4045000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
436000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2874000
orgo Increase Decrease In Amortization Of Lease Liabilities
IncreaseDecreaseInAmortizationOfLeaseLiabilities
5908000
orgo Increase Decrease In Amortization Of Lease Liabilities
IncreaseDecreaseInAmortizationOfLeaseLiabilities
4178000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2147000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3535000
orgo Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
8162000
orgo Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
1091000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
54000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
67000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5424000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3569000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4102000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15061000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4102000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15061000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
2813000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1875000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1174000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
332000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
180000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
528000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
83000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4335000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2290000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13861000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13782000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104338000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103290000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
90477000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89508000
us-gaap Interest Paid Net
InterestPaidNet
2744000
us-gaap Interest Paid Net
InterestPaidNet
2608000
us-gaap Income Taxes Paid
IncomeTaxesPaid
4796000
us-gaap Income Taxes Paid
IncomeTaxesPaid
3022000
orgo Cumulative Effect Adjustment For Adoption
CumulativeEffectAdjustmentForAdoption
615000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
709000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1882000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
817000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4253000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported results of operations during the reporting periods. In preparing the condensed consolidated financial statements, the estimates and assumptions that management considers to be significant and that present the greatest amount of uncertainty include: revenue recognition; sales returns and credit losses; inventory reserve; recognition and measurement of current and deferred income tax assets and liabilities; the assessment of recoverability of long-lived assets, including impairment and write-downs; and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> the valuation and recognition of stock-based compensation. Actual results and outcomes may differ significantly from those estimates and assumptions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents. The Company invests its cash equivalents in highly rated money market funds. Deposits may exceed federally insured limits, and the Company is exposed to credit risk on deposits in the event of default by the financial institutions to the extent account balances exceed the amount insured by the Federal Deposit Insurance Corporation (“FDIC”). However, the Company sweeps cash daily overnight and diversifies among financial institutions to reduce such exposure.</span></p>
CY2023Q4 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
5273000
CY2023Q4 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
5273000
CY2024Q2 orgo Group Purchase Organization Rebate
GroupPurchaseOrganizationRebate
1629000
orgo Group Purchase Organization Rebate
GroupPurchaseOrganizationRebate
3023000
CY2023Q2 orgo Group Purchase Organization Rebate
GroupPurchaseOrganizationRebate
1466000
orgo Group Purchase Organization Rebate
GroupPurchaseOrganizationRebate
2890000
CY2024Q2 us-gaap Revenues
Revenues
130234000
CY2023Q2 us-gaap Revenues
Revenues
117316000
us-gaap Revenues
Revenues
240210000
us-gaap Revenues
Revenues
224958000
CY2024Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
114457000
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
88859000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8512000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6860000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
105945000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
81999000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7475000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6921000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6860000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6362000
CY2024Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1064000
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-53000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2032000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
190000
CY2024Q2 orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-27000
CY2023Q2 orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-217000
orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-383000
orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-516000
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
3000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
8512000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6651000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
8512000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6651000
CY2024Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13674000
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12988000
CY2024Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
847000
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
810000
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
12362000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
14455000
CY2024Q2 us-gaap Inventory Net
InventoryNet
26883000
CY2023Q4 us-gaap Inventory Net
InventoryNet
28253000
CY2024Q2 orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
1954000
orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
4469000
CY2023Q2 orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
2057000
orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
3464000
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
145704000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
130347000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
75230000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
73186000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
89947000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
116228000
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3366000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6438000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2228000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4922000
CY2024Q2 orgo Write Down Of Capitalized Internal Use Software Costs
WriteDownOfCapitalizedInternalUseSoftwareCosts
3959000
CY2024Q2 us-gaap Goodwill
Goodwill
28772000
CY2023Q4 us-gaap Goodwill
Goodwill
28772000
CY2024Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
58523000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
44387000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14136000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
58523000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
42652000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15871000
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
834000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1735000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1229000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2459000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
19345000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18287000
CY2024Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
8916000
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
3075000
CY2024Q2 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
1881000
CY2023Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
2326000
CY2024Q2 orgo Accrued Milestone Payment Current
AccruedMilestonePaymentCurrent
2500000
CY2023Q4 orgo Accrued Milestone Payment Current
AccruedMilestonePaymentCurrent
2500000
CY2024Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
3885000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2799000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1489000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1087000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
38016000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30074000
CY2023Q1 orgo Number Of Reduction In Employees
NumberOfReductionInEmployees
71
CY2023Q1 orgo Percentage Of Reduction In Employees
PercentageOfReductionInEmployees
0.07
us-gaap Severance Costs1
SeveranceCosts1
1609000
CY2023Q2 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-126000
us-gaap Restructuring Charges
RestructuringCharges
1782000
CY2024Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
0
CY2023Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
298000
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
904000
us-gaap Payments For Restructuring
PaymentsForRestructuring
904000
CY2024Q2 us-gaap Restructuring Reserve
RestructuringReserve
0
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
1192000
us-gaap Restructuring Charges
RestructuringCharges
1782000
us-gaap Payments For Restructuring
PaymentsForRestructuring
2676000
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
298000
CY2024Q2 us-gaap Secured Debt
SecuredDebt
63750000
CY2023Q4 us-gaap Secured Debt
SecuredDebt
66563000
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
261000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
332000
CY2024Q2 orgo Secured Debt Net
SecuredDebtNet
63489000
CY2023Q4 orgo Secured Debt Net
SecuredDebtNet
66231000
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
2812000
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
6563000
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
54375000
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
63750000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9340046
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.6
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M28D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10267000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2640601
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.43
orgo Share Based Compensation Arrangement By Share Based Payment Award Options Total Exercised Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsTotalExercisedNumberOfShares
152250
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.18
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
254000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
139981
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.84
orgo Share Based Compensation Arrangement By Share Based Payment Award Options Canceled And Forfeited In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledAndForfeitedInPeriodIntrinsicValue
161000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11688416
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.4
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y29D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3029000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5536271
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.93
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y21D
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2269000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
10502883
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.49
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y10M9D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
2884000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2640601
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3554528
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-17043000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
5316000
us-gaap Profit Loss
ProfitLoss
-19143000
us-gaap Profit Loss
ProfitLoss
2347000
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132573153
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131293398
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132217463
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131189405
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132573153
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133066010
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132217463
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132475908
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2024Q2 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
1881000
CY2023Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
2326000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
576000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
58000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
109000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
11000
orgo Finance Lease Cost
FinanceLeaseCost
685000
orgo Finance Lease Cost
FinanceLeaseCost
69000
us-gaap Operating Lease Cost
OperatingLeaseCost
4364000
us-gaap Operating Lease Cost
OperatingLeaseCost
4779000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
1276000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
1491000
us-gaap Variable Lease Cost
VariableLeaseCost
2029000
us-gaap Variable Lease Cost
VariableLeaseCost
3370000
us-gaap Lease Cost
LeaseCost
8354000
us-gaap Lease Cost
LeaseCost
9709000
CY2024Q2 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
3454000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
3454000
CY2024Q2 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
1055000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
479000
CY2024Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
2399000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
2975000
us-gaap Operating Lease Payments
OperatingLeasePayments
6554000
us-gaap Operating Lease Payments
OperatingLeasePayments
5059000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
109000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
11000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
528000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
83000
CY2024Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y29D
CY2023Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M29D
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y3M7D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y5M26D
CY2024Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0791
CY2023Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0791
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0475
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0471
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
8848000
CY2024Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
639000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
9013000
CY2024Q2 us-gaap Finance Lease Liability Payments Due In Next Rolling Twelve Months
FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths
1278000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
7791000
CY2024Q2 us-gaap Finance Lease Liability Payments Due In Rolling Year Two
FinanceLeaseLiabilityPaymentsDueInRollingYearTwo
737000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
8119000
CY2024Q2 us-gaap Finance Lease Liability Payments Due In Rolling Year Three
FinanceLeaseLiabilityPaymentsDueInRollingYearThree
0
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
3580000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
15108000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
52459000
CY2024Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
2654000
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6986000
CY2024Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
215000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
45473000
CY2024Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
2439000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.014
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2503000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
260000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3863000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2205000
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-094009-index-headers.html Edgar Link pending
0000950170-24-094009-index.html Edgar Link pending
0000950170-24-094009.txt Edgar Link pending
0000950170-24-094009-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
orgo-20240630.htm Edgar Link pending
orgo-20240630.xsd Edgar Link pending
orgo-ex31_1.htm Edgar Link pending
orgo-ex31_2.htm Edgar Link pending
orgo-ex32_1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
orgo-20240630_htm.xml Edgar Link completed